Insider · CIK 0001777328

Gabay Avraham

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001777328

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-01	ORMPORAMED PHARMACEUTICALS INC.S Sale	Chief Financial Officer	SSale	−20K sh	$4.51	−$90.2K	861,076
2026-09-24	ORMPORAMED PHARMACEUTICALS INC.A Award	Chief Financial Officer	AAward	+209K sh	—	—	881,076
2026-08-20	LFWDLifeward Ltd.A Award	Director	AAward	+13.6K sh	—	—	13,643
2026-07-01	ORMPORAMED PHARMACEUTICALS INC.S Sale	Chief Financial Officer	SSale	−73.4K sh	$4.51	−$331K	671,785
2026-03-17	ORMPORAMED PHARMACEUTICALS INC.A Award	Chief Financial Officer	AAward	+95.9K sh	—	—	745,145
2026-01-22	ORMPORAMED PHARMACEUTICALS INC. · Performance Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−19K sh	—	—	0
2026-01-22	ORMPORAMED PHARMACEUTICALS INC.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+19K sh	—	—	649,256
2025-12-31	ORMPORAMED PHARMACEUTICALS INC.A Award	Chief Financial Officer	AAward	+81.2K sh	—	—	515,256
2025-12-31	ORMPORAMED PHARMACEUTICALS INC. · Performance Stock UnitsA Award	Chief Financial Officer	AAward	+19K sh	—	—	19,000
2025-12-31	ORMPORAMED PHARMACEUTICALS INC.A Award	Chief Financial Officer	AAward	+115K sh	—	—	630,256
2025-02-11	ORMPORAMED PHARMACEUTICALS INC.A Award	Chief Financial Officer	AAward	+34K sh	—	—	392,040
2025-02-11	ORMPORAMED PHARMACEUTICALS INC.A Award	Chief Financial Officer	AAward	+42K sh	—	—	434,040
2025-01-02	ORMPORAMED PHARMACEUTICALS INC.A Award	Chief Financial Officer	AAward	+188K sh	—	—	358,040
2024-11-07	ORMPORAMED PHARMACEUTICALS INC.A Award	Chief Financial Officer	AAward	+30K sh	—	—	170,040
2024-06-21	ORMPORAMED PHARMACEUTICALS INC.A Award	Chief Financial Officer	AAward	+140K sh	—	—	0
2021-02-03	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+40K sh	—	—	40,000
2019-09-12	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+33.1K sh	—	—	33,146
2019-06-17	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−33.1K sh	—	—	0
2019-06-17	ORMPORAMED PHARMACEUTICALS INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+33.1K sh	—	—	33,146

Recent filings

Accepted (ET)
Oct 24
Gabay Avraham0001213900-26-106531
SEC(opens sec.gov)
Sep 254
Gabay Avraham0001213900-26-103535
SEC(opens sec.gov)
Aug 244
Gabay Avraham0001178913-26-004241
SEC(opens sec.gov)
Jul 24
Gabay Avraham0001213900-26-075069
SEC(opens sec.gov)
Mar 184
Gabay Avraham0001213900-26-031011
SEC(opens sec.gov)
Jan 294
Gabay Avraham0001213900-26-009476
SEC(opens sec.gov)
Jan 24
Gabay Avraham0001213900-26-000658
SEC(opens sec.gov)
Feb 114
Gabay Avraham0001213900-25-012238
SEC(opens sec.gov)
Jan 64
Gabay Avraham0001213900-25-001166
SEC(opens sec.gov)
Nov 84
Gabay Avraham0001213900-24-095932
SEC(opens sec.gov)
Jun 214
Gabay Avraham0001213900-24-054781
SEC(opens sec.gov)
Feb 84
Gabay Avraham0001213900-21-007494
SEC(opens sec.gov)
Sep 164
Gabay Avraham0001213900-19-018197
SEC(opens sec.gov)
Jun 274
Gabay Avraham0001213900-19-011646
SEC(opens sec.gov)

Companies

Address

1185 AVENUE OF THE AMERICAS THIRD FLOOR

NEW YORK, NY, 10036